How to buy Inogen stock

Inogen, Inc is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Inogen employs 1,020 staff and has a trailing 12-month revenue of around USD$313.4 million.

How to buy shares in Inogen

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Inogen. Find the stock by name or ticker symbol: INGN. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Inogen reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Inogen, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Inogen. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Inogen share price

Use our graph to track the performance of INGN stocks over time.

Inogen shares at a glance

• Key figures

Information last updated 2021-02-24.

52-week range	USD$26.57 - USD$56.46
50-day moving average	USD$49.9245
200-day moving average	USD$36.9534
Wall St. target price	USD$41.75
PE ratio	98.7586
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$0.285

Buy Inogen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Inogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Inogen, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Inogen financials

Revenue TTM	USD$313.4 million
Gross profit TTM	USD$171.9 million
Return on assets TTM	-1.65%
Return on equity TTM	-0.6%
Profit margin	-0.66%
Book value	$15.938
Market capitalisation	USD$1.1 billion

TTM: trailing 12 months

Shorting Inogen shares

There are currently 1.1 million Inogen shares held short by investors – that's known as Inogen's "short interest". This figure is 0.8% down from 1.1 million last month.

There are a few different ways that this level of interest in shorting Inogen shares can be evaluated.

Inogen's "short interest ratio" (SIR)

Inogen's "short interest ratio" (SIR) is the quantity of Inogen shares currently shorted divided by the average quantity of Inogen shares traded daily (recently around 160040.36568214). Inogen's SIR currently stands at 7.11. In other words for every 100,000 Inogen shares traded daily on the market, roughly 7110 shares are currently held short.

However Inogen's short interest can also be evaluated against the total number of Inogen shares, or, against the total number of tradable Inogen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inogen's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Inogen shares in existence, roughly 50 shares are currently held short) or 0.119% of the tradable shares (for every 100,000 tradable Inogen shares, roughly 119 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Inogen.

Find out more about how you can short Inogen stock.

Inogen share price volatility

Over the last 12 months, Inogen's shares have ranged in value from as little as $26.57 up to $56.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 0.9616. This would suggest that Inogen's shares are less volatile than average (for this exchange).

Inogen overview

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Frequently asked questions

• What percentage of Inogen is owned by insiders or institutions?

  Currently 1.297% of Inogen shares are held by insiders and 97.964% by institutions.

• How many people work for Inogen?

  Latest data suggests 1,020 work at Inogen.

• When does the fiscal year end for Inogen?

  Inogen's fiscal year ends in December.

• Where is Inogen based?

  Inogen's address is: 326 Bollay Drive, Goleta, CA, United States, 93117

• What is Inogen's ISIN number?

  Inogen's international securities identification number is: US45780L1044

• What is Inogen's CUSIP number?

  Inogen's Committee on Uniform Securities Identification Procedures number is: 45780L104